SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-361732
Filing Date
2017-12-05
Accepted
2017-12-05 17:06:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A d471504ds3a.htm S-3/A 310250
2 GRAPHIC g471504g1103080235560.jpg GRAPHIC 2401
  Complete submission text file 0001193125-17-361732.txt   314797
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-221382 | Film No.: 171240411
SIC: 2834 Pharmaceutical Preparations